Psyched Wellness Ltd is pioneering research into the health benefits of Amanita Muscaria mushrooms proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Psyched Wellness Ltd.: Psyched Wellness Has Commenced Research on Muscimol for Various Ailments
Psyched Wellness Ltd. (
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has commenced research on Muscimol for various ailments, with a focus on mental health issues.
The research is led by Psyched Wellness s board member, Prof. David Nutt. Prof. Nutt is a psychiatrist at the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept. of Medicine, Hammersmith Hospital, Imperial College London and is the Chair of the Scientific Advisory Board for COMPASS Pathways.
Psyched Wellness Ltd.: Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (
CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has shipped its first batch of Amanita Muscaria extract to its CRO partner to commence the Pre-Clinical trials.
The Company sent 108 grams of highly concentrated Amanita Muscaria extract to its CRO s lab to begin the first phase of its Pre-Clinical Trial. This first batch of Amanita extract will be used in a study to determine the Maximum Tolerated Dose (MTD). The goal of the study is to determine the highest dose of our extract that will not cause unacceptable side effects or an overt toxicity in a defined period. This is a key first step in determining the appropriate dosage for our future products.
Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation)
(CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has successfully completed its first extraction of a legal psychedelic derived from Amanita Muscaria mushrooms.
The scientific team sourced dried Amanita Muscaria Mushroom caps from five separate suppliers from different geographic regions around the world. The dried Amanita was extracted using the Company s proprietary extraction protocol and was then packaged and sent with samples of the raw materials to an independent lab. The lab will be testing the extract for the necessary and desired compounds with a goal of providing the Company with a report within 5-7 days. The report will allow
Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Writing the Final Extraction Protocol, the Assembly of Safety & Efficacy Narratives, and Writing the Safety Data Sheet (SDS) for Its First Product
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation)
(CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has successfully completed a comprehensive process of lab experiments which have determined the Company s final extraction protocol, that will be used for the company s first line of products.
The company is also pleased to share that it has completed the assembly of the safety and efficacy narratives, and the writing of the safety data sheets (SDS) for its unique Amanita Mascara extract.